Prof. Dr. Ahmet TEMİZHAN

1. The predictive role of the FIB-4 index in identifying arrhythmic risk among patients with nonischemic dilated cardiomyopathy

Ekizler F. A., TEKİN TAK B., ÇAY S., Ergun A. C., TOK D., ŞENTÜRK B., et al.

International Journal of Cardiology , cilt.461, 2026 (SCI-Expanded, Scopus)

2. Heart Failure Among 173,000 Community-Dwelling Participants From 25 Low-, Middle-, and High-Income Countries in the PURE Study

Johansson Bartolini I., Joseph P., Islam S., Ramachan S. P., Rosengren A., Kruger I. M., et al.

Journal of the American College of Cardiology , cilt.87, sa.25, ss.3506-3517, 2026 (SCI-Expanded, Scopus)

3. Diet and Clinical Outcomes in a Heart Failure Population

Dehghan M., Ezekowitz J. A., Miller V., Lanas F., AlHabib K. F., Gomez-Mesa J. E., et al.

JACC: Heart Failure , cilt.14, sa.4, 2026 (SCI-Expanded, Scopus)

4. INFLAMMATION INDICES PREDICT STENT THROMBOSIS IN GERIATRIC PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION

Kafes H., TEKİN TAK B., Ergün A. C., Karaaslan Ö. Ç., TEMİZHAN A., Ekizler F. A.

Turk Geriatri Dergisi , cilt.29, sa.3, ss.285-295, 2026 (SCI-Expanded, SSCI, Scopus, TRDizin)

5. Secondary Prevention Medications in 17 Countries Grouped by Income Level (PURE): A Prospective Cohort Study

Joseph P., Szuba A., Lopez-Jaramillo P., Yusufali A. H., GÜLEÇ H. S., Kelishadi R., et al.

Journal of the American College of Cardiology , cilt.85, sa.5, ss.436-447, 2025 (SCI-Expanded, Scopus)

6. Blood pressure variability ratio: a novel marker associated with metabolic syndrome in patients without known cardiovascular disease

ÇETİN M. S., ÖZCAN ÇETİN E. H., Ulvan N., KÖNTE H. C., UÇAR ELALMIŞ Ö., ÖRNEK E., et al.

Acta Cardiologica , cilt.80, sa.8, ss.871-879, 2025 (SCI-Expanded, Scopus)

7. Guideline for the Use of Natriuretic Peptides in the Early Diagnosis and Management of Heart Failure in Primary Care (Joint Consensus Report by the Eurasian Society of Heart Failure and the Turkish Association of Family Medicine)

Çelik A., ZEREN ÖZTÜRK G., ÇAVUŞOĞLU Y., ARDIÇ C., Nalbantgil S., ARICA S., et al.

Balkan Medical Journal , cilt.42, sa.2, ss.94-107, 2025 (SCI-Expanded, Scopus, TRDizin)

8. Right atrioventricular groove epicardial fat tissue thickness is associated with right ventricular dysfunction in patients with acute pulmonary embolism

ÇETİN M. S., ÖZCAN Ç., KÖNTE H. C., ÖZCAN ÇETİN E. H., Ulvan N., Yazıcı B., et al.

International Journal of Cardiovascular Imaging , 2025 (SCI-Expanded, Scopus)

9. The prognostic value of ECG and right heart catheterization parameters in heart failure patients with reduced ejection fraction

Ocak K., Akın Y., ÖZCAN ÇETİN E. H., ÇETİN M. S., TEMİZHAN A.

Postepy w Kardiologii Interwencyjnej , cilt.21, sa.2, ss.237-246, 2025 (SCI-Expanded, Scopus)

10. Assessment of dyslipidemia management in Turkey using a Delphi panel

SİNAN Ü. Y., YILMAZ M. B., TEMİZHAN A., YÜKSEL U. Ç., GÜNGÖR B., Kemaloglu Oz T., et al.

Scientific Reports , cilt.14, sa.1, 2024 (SCI-Expanded, Scopus)

11. Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

Elshorbagy A., Lyons A. R., Vallejo-Vaz A. J., Stevens C. A., Dharmayat K. I., Brandts J., et al.

The Lancet Diabetes and Endocrinology , cilt.12, sa.11, ss.811-823, 2024 (SCI-Expanded, Scopus)

12. Baseline Characteristics and Clinical Insights from the ARTEMIS Registry: A Comprehensive Study of Peripartum Cardiomyopathy in Türkiye ARTEMIS Kayıt Çalışmasından Temel Özellikler ve Klinik Bilgiler: Türkiye’de Peripartum Kardiyomiyopati Üzerine Kapsamlı Bir Çalışma

Kayıkçıoğlu M., Biteker M., MUTLUER F. O., Güzel T., Yılmaz E., Demir E., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.52, sa.7, ss.474-483, 2024 (ESCI, Scopus)

13. Current Use of Sodium Glucose Co-transporter 2 Inhibitors in Heart Failure Therapy Kalp Yetersizliği Tedavisinde Sodyum Glukoz Ko-transporter 2 İnhibitörlerinin Güncel Kullanımı

ÇAVUŞOĞLU Y., Altay H., Çelik A., Güvenç T. S., Kılıçarslan B., Nalbantgil S., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.52, sa.6, ss.429-454, 2024 (ESCI, Scopus, TRDizin)

14. Mulibrey Nanism: A Case with Heart Failure Mulibrey Nanism: Bir Kalp Yetersizliği Olgusu

Çolakoğlu M. N., Kara M., Köprücü E., KORKMAZ A., TOPALOĞLU S., Altay F. P., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.52, sa.6, ss.464-467, 2024 (ESCI, Scopus, TRDizin)

15. Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia

Mulder J. W., Tromp T. R., Al-Khnifsawi M., Blom D. J., Chlebus K., Cuchel M., et al.

JAMA Cardiology , cilt.9, sa.4, ss.313-322, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Risk factors for recognized and unrecognized SARS-CoV-2 infection: a seroepidemiologic analysis of the Prospective Urban Rural Epidemiology (PURE) study

Leong D. P., Loeb M., Mony P. K., Rangarajan S., Mushtaha M., Miller M. S., et al.

Microbiology Spectrum , cilt.12, sa.2, 2024 (SCI-Expanded, Scopus)

17. Trends in heart failure between 2016 and 2022 in Türkiye (TRends-HF): a nationwide retrospective cohort study of 85 million individuals across entire population of all ages

Celik A., Ural D., ŞAHİN A., ÇÖLLÜOĞLU İ. T., Kanik E. A., ATA N., et al.

The Lancet Regional Health - Europe , cilt.33, 2023 (ESCI, Scopus)

18. Should we touch tricuspid valve at the time of LVAD implantation? A young patient series

Yavas S., KERVAN Ü., Karahan M., KOCABEYOĞLU S. S., Sert D. E., Ersoy O., et al.

International Journal of Artificial Organs , cilt.46, sa.8-9, ss.514-519, 2023 (SCI-Expanded, Scopus)

19. The association of hemodynamic markers of right ventricular dysfunction with SII index and clinical outcomes in reduced ejection fraction heart failure

Balci K., Erbay İ., DEMİRKAN B., BALCI M. M., TEMİZHAN A.

Medicine (United States) , cilt.102, sa.34, 2023 (SCI-Expanded, Scopus)

20. Risk Factors, Use of Preventive Drugs, and Cardiovascular Events in Diabetes Mellitus: The PURE Türkiye Cohort

Oğuz A., KILIÇKAP M., GÜLEÇ H. S., ALTUNTAŞ Y., Karşıdağ K., TEMİZHAN A., et al.

Anatolian Journal of Cardiology , cilt.27, sa.8, ss.453-461, 2023 (SCI-Expanded, Scopus, TRDizin)

21. How to Use Natriuretic Peptides in Patients with Heart Failure with Non-Reduced Ejection Fraction? A Position Paper from the Heart Failure Working Group of Turkish Society of Cardiology

Çelik A., Kılıçaslan B., TEMİZHAN A., Güvenç T. S., Altay H., ÇAVUŞOĞLU Y., et al.

Anatolian Journal of Cardiology , cilt.27, sa.6, ss.308-318, 2023 (SCI-Expanded, Scopus, TRDizin)

22. 2 Heart Failure Specialists Amid 2 Earthquakes 2 Decades Apart

TEMİZHAN A., YILMAZ M. B.

JACC: Heart Failure , cilt.11, sa.6, ss.715-716, 2023 (SCI-Expanded, Scopus)

23. Global Variations in Heart Failure Etiology, Management, and Outcomes

Joseph P., Roy A., Lonn E., Störk S., Floras J., Mielniczuk L., et al.

JAMA , cilt.329, sa.19, ss.1650-1661, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. Effect of renal function on the prognostic importance of chloride in patients with heart failure

Çetin Güvenç R., Güvenç T. S., TEMİZHAN A., Çavuşuğlu Y., Çelik A., YILMAZ M. B.

Journal of Investigative Medicine , cilt.71, sa.4, ss.339-349, 2023 (SCI-Expanded, Scopus)

25. Usefulness of Age, Creatinine and Ejection Fraction-Modification of Diet in Renal Disease Score for Predicting Survival in Patients with Heart Failure Utilidade da Idade, Creatinina e Fração de Ejeção – Modificação da Dieta no Escore de Doença Renal para Prever a Sobrevivência em Pacientes com Insuficiência Cardíaca

Güvenç R. Ç., Güvenç T. S., ÇAVUŞOĞLU Y., TEMİZHAN A., YILMAZ M. B.

Arquivos Brasileiros de Cardiologia , cilt.120, sa.12, 2023 (SCI-Expanded, Scopus)

26. A wide QRS tachycardia with the short and long ventriculoatrial interval in the presence of an atriofascicular pathway: What is the mechanism?

ÖZCAN ÇETİN E. H., Kara M., Merovci I., Kulekci F., Okumus K., Saglam O., et al.

Journal of Cardiovascular Electrophysiology , cilt.33, sa.11, ss.2398-2402, 2022 (SCI-Expanded, Scopus)

27. Relationship Between Preoperative NT-proBNP and Postoperative Adverse Events in Patients with Left Ventricular Assist Device

Beyazal O. F., KERVAN Ü., Karahan M., KOCABEYOĞLU S. S., Sert D. E., TEMİZHAN A., et al.

International Journal of Artificial Organs , cilt.45, sa.10, ss.817-825, 2022 (SCI-Expanded, Scopus)

28. Heart failure with non-reduced ejection fraction: Epidemiology, Pathophysiology, Phenotypes, Diagnosis and Treatment Approaches Düşük Ejeksiyon Fraksiyon Dışı Kalp Yetersizliği: Epidemiyoloji, Patofizyoloji, Fenotipler, Tanı ve Tedavi Yaklaşımları

ÇAVUŞOĞLU Y., Çelik A., Altay H., Nalbantgil S., Özden Ö., TEMİZHAN A., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.50, 2022 (ESCI, Scopus, TRDizin)

29. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

Tromp T. R., Hartgers M. L., Kees Hovingh P. G., Vallejo-Vaz A. J., Ray K. K., Soran H., et al.

The Lancet , cilt.399, sa.10326, ss.719-728, 2022 (SCI-Expanded, Scopus)

30. Variations in risks from smoking between high-income, middle-income, and low-income countries: an analysis of data from 179 000 participants from 63 countries

Sathish T., Teo K. K., Britz-McKibbin P., Gill B., Islam S., Paré G., et al.

The Lancet Global Health , cilt.10, sa.2, 2022 (SCI-Expanded, SSCI, Scopus)

31. Pre-Discharge and Post-Discharge Management and Treatment Optimization in Acute Heart Failure Akut Kalp Yetersizliğinde Taburculuk Öncesi ve Sonrası Hasta Yönetimi ve Tedavi Optimizasyonu

ÇAVUŞOĞLU Y., Altay H., Nalbantgil S., TEMİZHAN A., YILMAZ M. B.

Turk Kardiyoloji Dernegi Arsivi , cilt.50, sa.5, ss.378-394, 2022 (ESCI, Scopus, TRDizin)

32. Lipid Modification to Reduce Cardiovascular Risk in Secondary Prevention Patients with Special Emphasis on PCSK9 Inhibitor Requirement: An Analysis Based on Delphi Panel Approach Sekonder Önlem Hastalarında Kardiyovasküler Riski Azaltmada PCSK9 İnhibitör Gereksinimine Özel Vurgu ile Lipit Modifikasyonu: Delphi Panel Yaklaşımına Dayalı Bir Analiz

Kızılırmak P., Öngen Z., GÜLEÇ H. S., Kayıkçıoğlu M., KILIÇKAP M., ABACI A., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.50, sa.8, ss.554-560, 2022 (ESCI, Scopus, TRDizin)

33. Cost-of-disease of Heart Failure in Turkey: A Delphi Panel-based Analysis of Direct and Indirect Costs

ÇAVUŞOĞLU Y., Altay H., Aras D., Çelik A., ERTAŞ F. S., Kılıçaslan B., et al.

Balkan Medical Journal , cilt.39, sa.4, ss.282-289, 2022 (SCI-Expanded, Scopus, TRDizin)

34. Which is the best for the warfarin monitoring: Following up by fixed or variable physician?

Dinc Asarcikli L., Kafes H., ŞEN T., Ipek E. G., Beton O., TEMİZHAN A., et al.

Northern Clinics of Istanbul , cilt.9, sa.2, ss.93-101, 2022 (ESCI, Scopus, TRDizin)

35. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Vallejo-Vaz A. J., Stevens C. A., Lyons A. R., Dharmayat K. I., Freiberger T., Hovingh G. K., et al.

The Lancet , cilt.398, sa.10312, ss.1713-1725, 2021 (SCI-Expanded, Scopus)

36. Management of Hyperkalemia in Heart Failure

Altay H., Çavuşoğlu Y., Çelik A., DEMİR Ş., Kılıçarslan B., Nalbantgil S., et al.

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir , cilt.49, ss.1-32, 2021 (Scopus)

37. Midterm Results of Minimally Invasive Left Thoracotomy Fully Magnetically Levitated Left Ventricular Assist Device Implantation

KERVAN Ü., KOCABEYOĞLU S. S., Emre Sert D., Karahan M., TEMİZHAN A., DEMİRKAN B., et al.

ASAIO Journal , cilt.67, sa.9, ss.1006-1011, 2021 (SCI-Expanded, Scopus)

38. Time in therapeutic range values of patients using warfarin and factors that influence time in therapeutic range Varfarin kullanan hastalarda terapötik aralıkta geçen zaman ve terapötik aralıkta geçen zamanı etkileyen faktörler

Asarcıklı L. D., Kafes H., ŞEN T., Ipek E. G., Cebeci M., Gül M., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.49, sa.6, ss.463-473, 2021 (ESCI, Scopus, TRDizin)

39. Selvester score predicts implantable cardioverter defibrillator shocks in patients with non-ischemic cardiomyopathy

Arısoy F., ÖZCAN ÇELEBİ Ö., Erbay İ., TÜFEKÇİOĞLU O., AYDOĞDU S., TEMİZHAN A.

Journal of Arrhythmia , cilt.37, sa.4, ss.1046-1051, 2021 (ESCI, Scopus)

40. Health-Related Quality of Life and Mortality in Heart Failure The Global Congestive Heart Failure Study of 23000 Patients From 40 Countries

Johansson I., Joseph P., Balasubramanian K., McMurray J. J., Lund L. H., Ezekowitz J. A., et al.

Circulation , cilt.143, sa.22, ss.2129-2142, 2021 (SCI-Expanded, Scopus)

41. Resting heart rate and real-life treatment modalities in outpatients with left ventricular systolic dysfunction study: A multicenter, prospective, observational, and national registry

ÇAVUŞOĞLU Y., Kozan Ö., TEMİZHAN A., Küçükoğlu M. S.

Anatolian journal of cardiology , cilt.25, sa.5, ss.304-312, 2021 (SCI-Expanded, Scopus, TRDizin)

42. Lower levels of triiodothyronine are associated with poor hemodynamic profile and all-cause mortality in heart failure

ÖZCAN ÇETİN E. H., ÇETİN M. S., KÖNTE H. C., Ocak K., Yaman N. M., Hepsen S., et al.

Biomarkers in Medicine , cilt.15, sa.4, ss.273-283, 2021 (SCI-Expanded, Scopus)

43. Noncompliance with dietary salt restriction and outcomes in chronic heart failure: A propensity score matching analysis from treat-hf registry

ŞENTÜRK B., KAYA H., Celik A., Bekar L., Gungor H., Zoghi M., et al.

Haseki Tip Bulteni , cilt.59, sa.2, ss.114-121, 2021 (ESCI, Scopus, TRDizin)

44. The other side of the medallion in heart failure: Reverse metabolic syndrome

ÖZCAN ÇETİN E. H., ÇETİN M. S., Özbay M. B., Yaman N. M., KÖNTE H. C., Ekizler F. A., et al.

Nutrition, Metabolism and Cardiovascular Diseases , cilt.30, sa.11, ss.2041-2050, 2020 (SCI-Expanded, Scopus)

45. Risk of cardiovascular events in patients with metabolic syndrome: Results of a population-based prospective cohort study (PURE Turkey)

Oğuz A., KILIÇKAP M., GÜLEÇ H. S., ALTUNTAŞ Y., Karşıdağ K., TEMİZHAN A., et al.

Anatolian Journal of Cardiology , cilt.24, sa.3, ss.192-200, 2020 (SCI-Expanded, Scopus, TRDizin)

46. Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

Rossignol P., Crespo-Leiro M. G., Laroche C., Piepoli M., Filippatos G. S., Rosano G. M., et al.

European Journal of Heart Failure , cilt.22, sa.8, ss.1378-1389, 2020 (SCI-Expanded, Scopus)

47. Inhaled Iloprost and Oral Sildenafil Combination Therapy: Is it a Chance for Heart Transplant Candidacy?

KOCABEYOĞLU S. S., KERVAN Ü., Emre Sert D., TEMİZHAN A., DEMİRKAN B., Aygun E., et al.

Heart Lung and Circulation , cilt.29, sa.7, ss.1039-1045, 2020 (SCI-Expanded, Scopus)

48. Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry)

Kuman Tunçel Ö., Kayıkçıoğlu M., Pırıldar Ş., Yılmaz M., KAYNAR L., Aktan M., et al.

Journal of Clinical Lipidology , cilt.14, sa.3, ss.361, 2020 (SCI-Expanded, Scopus)

49. Sodium glucose co-transporter 2 inhibitors in heart failure therapy Kalp yetersizliği tedavisinde sodyum glikoz ko-transporter 2 inhibitörleri

ÇAVUŞOĞLU Y., Altay H., Cahn A., Çelik A., DEMİR Ş., Kılıçaslan B., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.48, sa.3, ss.330-354, 2020 (ESCI, Scopus, TRDizin)

50. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study

Dagenais G. R., Leong D. P., Rangarajan S., Lanas F., Lopez-Jaramillo P., Gupta R., et al.

The Lancet , cilt.395, sa.10226, ss.785-794, 2020 (SCI-Expanded, Scopus)

51. Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry

Lainšcak M., Milinkovic I., Polovina M., Crespo-Leiro M. G., Lund L. H., Anker S., et al.

European Journal of Heart Failure , cilt.22, sa.1, ss.92-102, 2020 (SCI-Expanded, Scopus)

52. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

Chioncel O., Mebazaa A., Maggioni A. P., Harjola V., Rosano G., Laroche C., et al.

European Journal of Heart Failure , cilt.21, sa.11, ss.1338-1352, 2019 (SCI-Expanded, Scopus)

53. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

Kapelios C. J., Lainscak M., Savarese G., Laroche C., Seferović P., Ruschitzka F., et al.

European Journal of Heart Failure , cilt.21, sa.11, ss.1383-1397, 2019 (SCI-Expanded, Scopus)

54. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

De Backer G., Mirrakhimov E., Tokgözoğlu L., Wood D., Jankowski P., Jankowski P., et al.

Atherosclerosis , cilt.285, ss.135-146, 2019 (SCI-Expanded, Scopus)

55. Blood Viscosity Should Not Be Overlooked When Evaluating the Fibrinogen to Albumin Ratio

ÖZCAN ÇETİN E. H., KÖNTE H. C., TEMİZHAN A.

Angiology , cilt.70, sa.5, ss.465-466, 2019 (SCI-Expanded, Scopus)

56. The prognostic value of positive T wave in lead aVR: A novel marker of adverse cardiac outcomes in peripartum cardiomyopathy

Ekizler F. A., ÇAY S., Kafes H., ÖZEKE Ö., ÖZCAN F., TOPALOĞLU S., et al.

Annals of Noninvasive Electrocardiology , cilt.24, sa.3, 2019 (SCI-Expanded, Scopus)

57. Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry)

Kayikcioglu M., Kuman-Tunçel O., Pirildar S., Yílmaz M., KAYNAR L., Aktan M., et al.

Journal of Clinical Lipidology , cilt.13, sa.3, ss.455-467, 2019 (SCI-Expanded, Scopus)

58. Association of estimated sleep duration and naps with mortality and cardiovascular events: A study of 116 632 people from 21 countries

Wang C., Bangdiwala S. I., Rangarajan S., Lear S. A., AlHabib K. F., Mohan V., et al.

European Heart Journal , cilt.40, sa.20, ss.1620-1629, 2019 (SCI-Expanded, Scopus)

59. Snapshot evaluation of heart failure in Turkey: Baseline characteristics of SELFIE-TR Türkiye'de kalp yetersizliginin anlik görüntüsü: SELFIE-TR bazal karakteristik özellikleri

YILMAZ M. B., Çelik A., ÇAVUŞOĞLU Y., Bekar L., Onrat E., Eren M., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.47, sa.3, ss.198-206, 2019 (Scopus, TRDizin)

60. The association of estimated whole blood viscosity with hemodynamic parameters and prognosis in patients with heart failure

ÖZCAN ÇETİN E. H., ÇETİN M. S., Çaǧli K., TEMİZHAN A., Özbay M. B., Ediboglu E., et al.

Biomarkers in Medicine , cilt.13, sa.2, ss.69-82, 2019 (SCI-Expanded, Scopus)

61. The association between left ventricular mass index and coronary collateral circulation in patients with chronic total occlusion

ÇETİN M. S., ÖZCAN ÇETİN E. H., Ocak K., ÖZCAN ÇELEBİ Ö., Aras D., TEMİZHAN A., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.47, sa.1, ss.21-28, 2019 (Scopus, TRDizin)

62. Vaccination of adults with heart failure and chronic heart conditions: Expert opinion Kalp yetersizliği ve kronik kalp hastalıklarında erişkin aşılama: Uzman görüşü

Çelik A., Altay H., AZAP A., ÇAVUŞOĞLU Y., Nalbantgil S., ŞENOL E., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.46, sa.8, ss.723-734, 2018 (Scopus, TRDizin)

63. Yazarın yanıtı

ÖZCAN ÇETİN E. H., ÇETİN M. S., TEMİZHAN A.

Turk Kardiyoloji Dernegi Arsivi , cilt.46, sa.8, ss.744-745, 2018 (Scopus, TRDizin)

64. What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?

Kayikcioglu M., Tokgozoglu L., Dogan V., Ceyhan C., Tuncez A., KUTLU M., et al.

Atherosclerosis , cilt.277, ss.341-346, 2018 (SCI-Expanded, Scopus)

65. Increased myocardial energy expenditure in cardiac syndrome X: More work, more pain Kardiyak sendrom X’li hastalarda artmış miyokart enerji tüketimi: Çok iş, çok ağrı

ÇETİN M. S., ÖZCAN ÇETİN E. H., CANPOLAT U., ERDÖL M. A., Aydın S., ÖZCAN ÇELEBİ Ö., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.46, sa.6, ss.446-454, 2018 (Scopus, TRDizin)

66. The impact of admission cystatin C levels on in-hospital and three-year mortality rates in acute decompensated heart failure

Selcuk H., Selcuk M. T., MADEN O., Balci K. G., Tekeli S., ÖZCAN ÇETİN E. H., et al.

Cardiovascular Journal of Africa , cilt.29, sa.5, ss.305-309, 2018 (SCI-Expanded, Scopus)

67. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

Canepa M., Fonseca C., Chioncel O., Laroche C., Crespo-Leiro M., Coats A., et al.

JACC: Heart Failure , cilt.6, sa.6, ss.452-462, 2018 (SCI-Expanded, Scopus)

68. A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)

Kayikcioglu M., Tokgozoglu L., Yilmaz M., KAYNAR L., Aktan M., Durmuş R. B., et al.

Atherosclerosis , cilt.270, ss.42-48, 2018 (SCI-Expanded, Scopus)

69. Prognostic significance of myocardial energy expenditure and myocardial efficiency in patients with heart failure with reduced ejection fraction

ÇETİN M. S., ÖZCAN ÇETİN E. H., CANPOLAT U., Sasmaz H., TEMİZHAN A., AYDOĞDU S.

International Journal of Cardiovascular Imaging , cilt.34, sa.2, ss.211-222, 2018 (Scopus)

70. Response to the letter concerning the article: “Platelet distribution width and plateletcrit: Novel biomarkers of ST elevation myocardial infarction in young patients”

ÖZCAN ÇETİN E. H., Serkan Cetin M., Akdi A., Aras D., TOPALOĞLU S., TEMİZHAN A., et al.

Kardiologia Polska , cilt.76, sa.1, ss.228, 2018 (SCI-Expanded, Scopus)

71. Tp–e interval and Tp–e/QT ratio in patients with Human Immunodeficiency Virus

Ünal S., YAYLA Ç., ACAR B., Ertem A. G., AKBOĞA M. K., Gökaslan S., et al.

Journal of Infection and Public Health , cilt.11, sa.1, ss.35-38, 2018 (SCI-Expanded, Scopus)

72. Evaluation of patients with metabolic syndrome according to the health belief model scale in obesity Metabolik sendromlu hastalarin obezitede sağlik inanç modeli ölçeği'ne göre değerlendirilmesi

Kilinç F. N., Çakir B., Daşgin H., TEMİZHAN A.

Medical Journal of Bakirkoy , cilt.14, sa.1, ss.76-84, 2018 (Scopus, TRDizin)

73. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study

Dehghan M., Mente A., Zhang X., Swaminathan S., Li W., Mohan V., et al.

The Lancet , cilt.390, sa.10107, ss.2050-2062, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

74. Platelet distribution width and plateletcrit: Novel biomarkers of ST elevation myocardial infarction in young patients

ÇETİN M. S., ÖZCAN ÇETİN E. H., Akdi A., Aras D., TOPALOĞLU S., TEMİZHAN A., et al.

Kardiologia Polska , cilt.75, sa.10, ss.1005-1012, 2017 (SCI-Expanded, Scopus)

75. Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study

Mente A., Dehghan M., Rangarajan S., McQueen M., Dagenais G., Wielgosz A., et al.

The Lancet Diabetes and Endocrinology , cilt.5, sa.10, ss.774-787, 2017 (SCI-Expanded, Scopus)

76. Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Attaei M. W., Khatib R., McKee M., Lear S., Dagenais G., Igumbor E. U., et al.

The Lancet Public Health , cilt.2, sa.9, 2017 (Scopus)

77. Turkish assessment of SURF (SUrvey of Risk Factor Management) study: Control rates of cardiovascular risk factors derived from databases of 15 different levels of health centers in Turkey

Tokgözoǧlu L., Oǧuz A., Balci M. K., TEMİZHAN A., Altunoǧlu E. G., Bektǎ O., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.45, sa.5, ss.398-407, 2017 (Scopus, TRDizin)

78. Relationship between Serum Albumin Level and Monocyte-to-High-Density Lipoprotein Cholesterol Ratio with Saphenous Vein Graft Disease in Coronary Bypass

AKBOĞA M. K., YAYLA Ç., Balci K. G., ÖZEKE Ö., MADEN O., Kisacik H., et al.

Thoracic and Cardiovascular Surgeon , cilt.65, sa.4, ss.315-321, 2017 (SCI-Expanded, Scopus)

79. Manual heating of the radial artery (Balbay maneuver) to facilitate radial puncture prior to transradial coronary catheterization Aquecimento manual da artéria radial (manobra de Balbay) para facilitar a punção radial antes da cateterização coronária

Ünal S., ACAR B., YAYLA Ç., BALCI M. M., Ertem A. G., Kara M., et al.

Revista Portuguesa de Cardiologia , cilt.36, sa.6, ss.409-414, 2017 (SCI-Expanded, Scopus)

80. Influence of influenza vaccination on recurrent hospitalization in patients with heart failure Einfluss der Grippeimpfung auf wiederkehrende Hospitalisierungen von Herzinsuffizienzpatienten

KAYA H. İ., Beton O., Acar G., TEMİZHAN A., ÇAVUŞOĞLU Y., GÜRAY Ü., et al.

Herz , cilt.42, sa.3, ss.307-315, 2017 (SCI-Expanded, Scopus)

81. Predictors of neurologically favorable survival among patients with out-of-hospital cardiac arrest: A tertiary referral hospital experience

Balci K. G., BALCI M. M., Şen F., AKBOĞA M. K., Kalender E., Yilmaz S., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.45, sa.3, ss.254-260, 2017 (Scopus, TRDizin)

82. The Relationship between Resting Heart Rate and SYNTAX Score in Patients with Stable Coronary Artery Disease

Yilmaz S., Sen F., AKBOĞA M. K., Balci K. G., Aras D., TEMİZHAN A., et al.

Angiology , cilt.68, sa.2, ss.168-173, 2017 (SCI-Expanded, Scopus)

83. Platelet-to-lymphocyte ratio as a novel marker of in-hospital and long-term adverse outcomes among patients with acute pulmonary embolism: A single center large-scale study

ÖZCAN ÇETİN E. H., ÇETİN M. S., CANPOLAT U., Akdi A., Aras D., TEMİZHAN A., et al.

Thrombosis Research , cilt.150, ss.33-40, 2017 (SCI-Expanded, Scopus)

84. Trigliserit nedir? Normal fizyolojideki yeri nedir?

Çetinkalp Ş., Koylan N., ÖZER N., Onat A., Gökhan Özgen A., Lale Koldaş Z., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.45, ss.1-63, 2017 (Scopus, TRDizin)

85. Effectiveness of computed tomography attenuation values in characterization of pericardial effusion

ÇETİN M. S., ÖZCAN ÇETİN E. H., Özdemir M., TOPALOĞLU S., Aras D., TEMİZHAN A., et al.

Anatolian Journal of Cardiology , cilt.17, sa.4, ss.322-327, 2017 (SCI-Expanded, Scopus, TRDizin)

86. Iron deficiency and anemia in heart failure Kalp yetersizliğinde demir eksikliği ve anemi

ÇAVUŞOĞLU Y., Altay H., Çetiner M., Güvenç T. S., TEMİZHAN A., Ural D., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.45, ss.1-38, 2017 (Scopus, TRDizin)

87. Right ventricular dysfunction complicates time in therapeutic range in heart failure patients receiving warfarin

Beton O., Asarcikli L. D., ŞEN T., Ipek E. G., Kafes H., Yaman M., et al.

Pharmacology , cilt.99, sa.1-2, ss.19-26, 2017 (SCI-Expanded, Scopus)

88. Post-discharge heart failure monitoring program in turkey: Hit-point

ÇAVUŞOĞLU Y., Zoghi M., Eren M., Bozçalı E., Kozdağ G., ŞENTÜRK T., et al.

Anatolian Journal of Cardiology , cilt.17, sa.2, ss.107-112, 2017 (SCI-Expanded, Scopus, TRDizin)

89. 2016 ESC and ACC/AHA/HFSA heart failure guideline updates: Changes, similarities, differences, and unresolved isssues 2016 Avrupa ve Amerika Kalp Yetersizliǧi Kilavuz Güncellemeleri: Yenilikler, benzerlikler, farkliliklar ve netlik kazanmamiş konular

Sari I., Çavuşoǧlu Y., TEMİZHAN A., YILMAZ M. B., Eren M.

Turk Kardiyoloji Dernegi Arsivi , cilt.44, sa.8, ss.625-636, 2016 (Scopus, TRDizin)

90. Turkish registry for diagnosis and treatment of acute heart failure: TAKTIK study

Eren M., Zoghi M., Tuncer M., Çavuşoǧlu Y., Demirbaǧ R., Şahin M., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.44, sa.8, ss.637-646, 2016 (Scopus, TRDizin)

91. Monocyte to HDL Cholesterol Ratio Predicts Coronary Artery Disease Severity and Future Major Cardiovascular Adverse Events in Acute Coronary Syndrome

ÇETİN M. S., ÖZCAN ÇETİN E. H., Kalender E., Aydin S., TOPALOĞLU S., Kisacik H. L., et al.

Heart Lung and Circulation , cilt.25, sa.11, ss.1077-1086, 2016 (SCI-Expanded, Scopus)

92. The association between whole blood viscosity and coronary collateral circulation in patients with chronic total occlusion

ÇETİN M. S., ÖZCAN ÇETİN E. H., Balci K. G., Aydin S., Ediboglu E., Bayraktar M. F., et al.

Korean Circulation Journal , cilt.46, sa.6, ss.784-790, 2016 (SCI-Expanded, Scopus)

93. Usefulness of the monocyte-to-high-density lipoprotein cholesterol ratio to predict bare metal stent restenosis

Yilmaz S., AKBOĞA M. K., Sen F., Balci K. G., Aras D., TEMİZHAN A., et al.

Biomarkers in Medicine , cilt.10, sa.9, ss.959-966, 2016 (SCI-Expanded, Scopus)

94. Relationship between functional capacity and socioeconomic status in a cohort of Turkish heart failure patients

Kaya H., Ege M. R., Zorlu A., Beton O., Güngör H., TEMİZHAN A., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.44, sa.6, ss.481-487, 2016 (Scopus, TRDizin)

95. Fragmented QRS Complex Predicts In-Hospital Adverse Events and Long-Term Mortality in Patients with Acute Pulmonary Embolism

ÇETİN M. S., ÖZCAN ÇETİN E. H., Arisoy F., Kuyumcu M. S., TOPALOĞLU S., Aras D., et al.

Annals of Noninvasive Electrocardiology , cilt.21, sa.5, ss.470-478, 2016 (SCI-Expanded, Scopus)

96. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions

Crespo-Leiro M. G., Anker S. D., Maggioni A. P., Coats A. J., Filippatos G., Ruschitzka F., et al.

European Journal of Heart Failure , cilt.18, sa.6, ss.613-625, 2016 (SCI-Expanded, Scopus)

97. Prognostic significance of whole blood viscosity estimated by de Simone's formula in ST-elevation myocardial infarction

ÖZCAN ÇETİN E. H., ÇETİN M. S., CANPOLAT U., Aydin S., Aras D., TOPALOĞLU S., et al.

Biomarkers in Medicine , cilt.10, sa.5, ss.495-511, 2016 (SCI-Expanded, Scopus)

98. Usefulness of Fragmented QRS Complex to Predict Arrhythmic Events and Cardiovascular Mortality in Patients with Noncompaction Cardiomyopathy

ÇETİN M. S., ÖZCAN ÇETİN E. H., CANPOLAT U., ÇAY S., TOPALOĞLU S., TEMİZHAN A., et al.

American Journal of Cardiology , cilt.117, sa.9, ss.1516-1523, 2016 (SCI-Expanded, Scopus)

99. Platelet to lymphocyte ratio as a prognostic marker of in-hospital and long-term major adverse cardiovascular events in ST-segment elevation myocardial infarction

ÖZCAN ÇETİN E. H., ÇETİN M. S., Aras D., TOPALOĞLU S., TEMİZHAN A., Kisacik H. L., et al.

Angiology , cilt.67, sa.4, ss.336-345, 2016 (SCI-Expanded, Scopus)

100. The Relationship between Epicardial Adipose Tissue Thickness and Infarct-Related Artery Patency in Patients with ST-Segment Elevation Myocardial Infarction

Sen F., Yilmaz S., Balci K. G., Gül M., BALCI M. M., AKBOĞA M. K., et al.

Angiology , cilt.67, sa.3, ss.281-286, 2016 (SCI-Expanded, Scopus)

101. Epicardial Adipose Tissue Thickness, Is It a Reason or a Consequence?

Yllmaz S., Sen F., TEMİZHAN A.

Angiology , cilt.67, sa.3, ss.293, 2016 (SCI-Expanded, Scopus)

102. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: An analysis of the PURE study data

Khatib R., McKee M., Shannon H., Chow C., Rangarajan S., Teo K., et al.

The Lancet , cilt.387, sa.10013, ss.61-69, 2016 (SCI-Expanded, Scopus)

103. The association between mean platelet volume and spontaneous echocardiographic contrast or left atrial thrombus in patients with mitral stenosis

Balcı K. G., MADEN O., BALCI M. M., Şen F., Ünal S., Kuyumcu S., et al.

Anatolian Journal of Cardiology , cilt.16, sa.11, ss.863-867, 2016 (SCI-Expanded, Scopus, TRDizin)

104. An overlooked parameter in coronary slow flow phenomenon: Whole blood viscosity

ÇETİN M. S., ÖZCAN ÇETİN E. H., CANPOLAT U., Aydin S., TEMİZHAN A., TOPALOĞLU S., et al.

Biomarkers in Medicine , cilt.9, sa.12, ss.1311-1321, 2015 (SCI-Expanded, Scopus)

105. Perceived Benefits of Implantable Cardioverter Defibrillator Implantation among Heart Failure Patients and Its Relation to Quality of Life: A Cross-Sectional Study

Balci K. G., BALCI M. M., AKBOĞA M. K., Sen F., ACAR B., Yılmaz S., et al.

Cardiology and Therapy , cilt.4, sa.2, ss.155-165, 2015 (Scopus)

106. The relationship between Vitamin D levels and nondipper hypertension

Yilmaz S., Sen F., ÖZEKE Ö., TEMİZHAN A., TOPALOĞLU S., Aras D., et al.

Blood Pressure Monitoring , cilt.20, sa.6, ss.330-334, 2015 (SCI-Expanded, Scopus)

107. Diagnosis and management of acute heart failure

Ural D., ÇAVUŞOĞLU Y., Eren M., KARAÜZÜM K., TEMİZHAN A., YILMAZ M. B., et al.

Anadolu Kardiyoloji Dergisi , cilt.15, sa.11, ss.860-889, 2015 (Scopus)

108. Practical approaches for the treatment of chronic heart failure: Frequently asked questions, overlooked points and controversial issues in current clinical practice

ÇAVUŞOĞLU Y., Altay H., Ekmekçi A., Eren M., Küçükoğlu M. S., Nalbantgil S., et al.

Anadolu Kardiyoloji Dergisi , cilt.15, ss.1-60, 2015 (Scopus)

109. Non-O blood groups can be a prognostic marker of in-hospital and long-term major adverse cardiovascular events in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention

ÇETİN M. S., ÖZCAN ÇETİN E. H., Aras D., TOPALOĞLU S., TEMİZHAN A., Kisacik H. L., et al.

Thrombosis Research , cilt.136, sa.3, ss.599-605, 2015 (SCI-Expanded, Scopus)

110. Kararli anjina tedavisinde ranolazini kime, nasil kullaniyorsunuz?

TEMİZHAN A.

Turk Kardiyoloji Dernegi Arsivi , cilt.43, sa.5, ss.499-500, 2015 (Scopus, TRDizin)

111. Lymphocytopenia is associated with poor NYHA functional class in chronic heart failure patients with reduced ejection fraction

Yücel H., Ege M. R., Zorlu A., Kaya H., Beton O., Güngör H., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.43, sa.5, ss.427-433, 2015 (Scopus, TRDizin)

112. Epicardial adipose tissue is related to coronary collateral vessel formation in patients with acute coronary syndrome

Sen F., Yilmaz S., Sen Ö., Balc K. G., Duman I., TOPALOĞLU S., et al.

Scandinavian Cardiovascular Journal , cilt.49, sa.3, ss.130-135, 2015 (SCI-Expanded, Scopus)

113. Uric acid may cause of erectile dysfunction in hypertensive patients?

Yilmaz S., Tüfekçioʇlu O., TEMİZHAN A., Aydoʇdu S.

Blood Pressure , cilt.24, sa.3, ss.196-197, 2015 (SCI-Expanded, Scopus)

114. Abdominal Obesity Perception in Turkish Population

Oguz A., TEMİZHAN A., ALTUNTAŞ Y., Karsidag K., GÜLEÇ H. S., Telci Caklili O.

Journal of Nutrition Education and Behavior , cilt.47, sa.2, 2015 (SCI-Expanded, Scopus)

115. Fatal prosthetic mitral valve encroachment during transcatheter aortic valve implantation

ACAR B., Kuyumcu S., Aydin S., Kara M., Karakurt M., ÖZEKE Ö., et al.

International Journal of Cardiology , cilt.182, sa.C, ss.235-236, 2015 (SCI-Expanded, Scopus)

116. Prospective Urban Rural Epidemiology (PURE) study: Baseline characteristics of the household sample and comparative analyses with national data in 17 countries

Corsi D. J., Subramanian S., Chow C. K., McKee M., Chifamba J., Dagenais G., et al.

American Heart Journal , cilt.166, sa.4, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

117. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

Maggioni A. P., Anker S. D., Dahlström U., Filippatos G., Ponikowski P., Zannad F., et al.

European Journal of Heart Failure , cilt.15, sa.10, ss.1173-1184, 2013 (SCI-Expanded, Scopus)

118. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries

Chow C. K., Teo K. K., Rangarajan S., Islam S., Gupta R., Avezum A., et al.

JAMA , cilt.310, sa.9, ss.959-968, 2013 (SCI-Expanded, Scopus)

119. Monocyte heterogeneity in myocardial infarction with and without ST elevation and its association with angiographic findings

Arslan U., Kocaoǧlu I., BALCI M. M., Gülkan B., Falay M. Y., TEMİZHAN A.

Coronary Artery Disease , cilt.24, sa.5, ss.404-411, 2013 (SCI-Expanded, Scopus)

120. The effects of cardiac resynchronization treatment on autonomic functions aside from functional status in heart failure Kardiyak resenkronizasyon tedavisinin otonom sistem üzerine fonksiyonel kapasite ötesinde etkileri

Arslan U., BALCI M. M., Kocaoǧlu I., Çimen T., Kalayci S., TEMİZHAN A.

Anadolu Kardiyoloji Dergisi , cilt.13, sa.5, ss.439-445, 2013 (SCI-Expanded, Scopus, TRDizin)

121. Comparison of serum gamma-glutamyltransferase levels between patients with cardiac syndrome X and healthy asymptomatic individuals

Demir B., TEMİZHAN A., Keskin G., Baser K., Turak O., ÇAY S.

Kardiologia Polska , cilt.70, sa.1, ss.31-37, 2012 (SCI-Expanded, Scopus)

122. The prevalence of microalbuminuria and relevant cardiovascular risk factors in Turkish hypertensive patients

Kozan Ö., ÖZCAN E. E., Sancaktar O., Kabakci G., Sözcüer A. H., Kerpeten A., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.39, sa.8, ss.635-645, 2011 (Scopus, TRDizin)

123. Kalp yetersizliǧi tedavisini izlemede BNP düzeyi ölçümü yapiyor musunuz? SUT'de BNP geri ödemesinin sadece akut kalp yetersizliǧi ayirici tanisi ile sinirli olmasini doǧru buluyor musunuz?

TEMİZHAN A.

Turk Kardiyoloji Dernegi Arsivi , cilt.39, sa.6, ss.529, 2011 (Scopus, TRDizin)

124. EUROASPIRE III: A comparison between Turkey and Europe EUROASPIRE III: Türkiye ile Avrupa'nin karşilaştirilmasi

Tokgözoǧlu L., KAYA E. B., Erol Ç., Ergene O., AYDOĞDU S., Tekin M., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.38, sa.3, ss.164-172, 2010 (Scopus, TRDizin)

125. The relationship between insulin resistance and left ventricular systolic and diastolic functions and functional capacity in patients with chronic heart failure and metabolic syndrome Kronik kalp yetersizliǧi olan metabolik sendromlu hastalarda insülin direncinin sol ventrikül sistolik ve diyastolik fonksiyonu ve fonksiyonel kapasite ile ilişkisi

Başyiǧit F., TEMİZHAN A., Malçok Ö., Kahraman E., Çakal E., Selçuk M. T., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.38, sa.3, ss.173-181, 2010 (Scopus, TRDizin)

126. Impact of metabolic syndrome on future cardiovascular events in patients with first acute myocardial infarction

Selcuk H., TEMİZHAN A., Selcuk M. T., ŞEN T., MADEN O., Tekeli S., et al.

Coronary Artery Disease , cilt.20, sa.6, ss.370-375, 2009 (SCI-Expanded, Scopus)

127. Decreased plasma concentrations of adiponectin in patients with slow coronary flow

Selcuk H., Selcuk M. T., TEMİZHAN A., MADEN O., Saydam G. S., Ulupinar H., et al.

Heart and Vessels , cilt.24, sa.1, ss.1-7, 2009 (SCI-Expanded, Scopus)

128. The effect of plasma asymmetric dimethylarginine (ADMA) level and L-arginine/ADMA ratio on the development of coronary collaterals Plazma asimetrik dimetilarginin (ADMA) düzeyi ve L-arginin/ADMA oraninin koroner kollateral gelişimi üzerine etkisi

Selçuk M. T., Selçuk H., TEMİZHAN A., MADEN O., Ulupinar H., Baysal E., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.36, sa.3, ss.150-155, 2008 (Scopus, TRDizin)

129. Impact of plasma adiponectin levels to the presence and severity of coronary artery disease in patients with metabolic syndrome

Selcuk M. T., Selcuk H., TEMİZHAN A., MADEN O., Saydam G. S., Dogan M., et al.

Coronary Artery Disease , cilt.19, sa.2, ss.79-84, 2008 (SCI-Expanded, Scopus)

130. The effect of high-dose aspirin pre-treatment on the incidence of myonecrosis following elective coronary stenting

GÜLEÇ H. S., ÖZDÖL Ç., Vurgun K., Selcuk T., TURHAN S., Duzen V., et al.

Atherosclerosis , cilt.197, sa.1, ss.171-176, 2008 (SCI-Expanded, Scopus)

131. Aspirin in cardiovascular prevention: Does the approach differ by gender? Kardiyovasküler korumada aspirin: Cinsiyete göre farkli bir yaklaşim var mi?

TEMİZHAN A.

Anadolu Kardiyoloji Dergisi , cilt.7, sa.SUPPL. 2, ss.2-4, 2007 (Scopus, TRDizin)

132. The effect of percutaneous balloon mitral valvuloplasty on N-terminal- pro B-type natriuretic peptide plasma levels in mitral stenosis

Selcuk M. T., Selcuk H., MADEN O., Erbay A. R., TEMİZHAN A., Aksu T., et al.

International Heart Journal , cilt.48, sa.5, ss.579-590, 2007 (SCI-Expanded, Scopus)

133. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow

Selcuk M. T., Selcuk H., TEMİZHAN A., MADEN O., Ulupinar H., Baysal E., et al.

Coronary Artery Disease , cilt.18, sa.7, ss.545-551, 2007 (SCI-Expanded, Scopus)

134. Relationship between inflammation and atrial fibrillation in patients with isolated rheumatic mitral stenosis

Timur Selcuk M., Selcuk H., MADEN O., TEMİZHAN A., Aksu T., Dogan M., et al.

Journal of Heart Valve Disease , cilt.16, sa.5, ss.468-474, 2007 (SCI-Expanded, Scopus)

135. Effect of obesity on saphenous vein graft stenosis in patients with postoperative recurrent angina

Selcuk M. T., Selcuk H., MADEN O., ÖZEKE Ö., Ulupinar H., TEMİZHAN A., et al.

Acta Cardiologica , cilt.62, sa.4, ss.397-402, 2007 (SCI-Expanded, Scopus)

136. The influence of homocysteine levels on endothelial function and their relation with microvascular complications in T2DM patients without macrovascular disease

KARABAĞ T., Kaya A., TEMİZHAN A., Koç F., Yavuz S., Çam S.

Acta Diabetologica , cilt.44, sa.2, ss.69-75, 2007 (SCI-Expanded, Scopus)

137. Prevalence of the metabolic syndrome among Turkish adults

Kozan O., Oguz A., ABACI A., Erol C., Ongen Z., TEMİZHAN A., et al.

European Journal of Clinical Nutrition , cilt.61, sa.4, ss.548-553, 2007 (SCI-Expanded, Scopus)

138. Abdominal obesity and cardiometabolic risk Addominal obezite ve kardiyometabolik risk

TEMİZHAN A.

Anadolu Kardiyoloji Dergisi , cilt.7, sa.1, ss.35-36, 2007 (Scopus, TRDizin)

139. The effects of mobile phones on pacemaker function

Tandogan I., TEMİZHAN A., Yetkin E., Guray Y., Ileri M., Duru E., et al.

International Journal of Cardiology , cilt.103, sa.1, ss.51-58, 2005 (Scopus)

140. The influence of aldosterone on the development of left ventricular geometry and hypertrophy in patients with essential hypertension

Soylu A., TEMİZHAN A., Duzenli M. A., Sokmen G., Koylu O., Telli H. H.

Japanese Heart Journal , cilt.45, sa.5, ss.807-821, 2004 (Scopus)

141. Ventricular function abnormalities in active rheumatoid arthritis: A Doppler echocardiographic study

Levendoglu F., TEMİZHAN A., Ugurlu H., Ozdemir A., Yazici M.

Rheumatology International , cilt.24, sa.3, ss.141-146, 2004 (Scopus)

142. Slow coronary flow Yavaş koroner akim

TEMİZHAN A.

Anadolu Kardiyoloji Dergisi , cilt.3, sa.3, ss.227-228, 2003 (Scopus)

143. Effects of Ramadan fasting on stroke

Çomoǧlu S., TEMİZHAN A., Peşinci E., Tandoǧan I., Özbakir Ş.

Turkish Journal of Medical Sciences , cilt.33, sa.4, ss.237-241, 2003 (Scopus, TRDizin)

144. Can P wave parameters obtained from 12-lead surface electrocardiogram be a predictor for atrial fibrillation in patients who have structural heart disease?

Altunkeser B. B., Özdemir K., Gök H., TEMİZHAN A., Tokaç M., KARABAĞ T.

Angiology , cilt.54, sa.4, ss.475-479, 2003 (SCI-Expanded, Scopus)

145. Analysis of the myocardial velocities in patients with mitral stenosis

Özdemir K., Altunkeser B. B., Gök H., Içli A., TEMİZHAN A.

Journal of the American Society of Echocardiography , cilt.15, sa.12, ss.1472-1478, 2002 (SCI-Expanded, Scopus)

146. Left ventricular hypertrophy increases the frequency of ventricular arrhythmia in hypertensive patients Sol ventrikül hipertrofisi hipertansif hastalarda ventriküler aritmi sikliǧini arttiriyor

Özdemir A., Hüseyin H., TEMİZHAN A., Altunkeser B. B., Özdemir K., Alpaslan M., et al.

Anadolu Kardiyoloji Dergisi , cilt.2, sa.4, ss.293-299, 2002 (Scopus)

147. The effects of mobile phones on pacemaker functions

Tandoǧan I., TEMİZHAN A., Yetkin E., Güray Y., Ileri M., Duru E., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.30, sa.11, ss.699, 2002 (Scopus, TRDizin)

148. Giant pulmonary artery aneurysm

Huseyin Telli H., Gormus N., TEMİZHAN A., Solak H.

European Journal of Cardio-thoracic Surgery , cilt.21, sa.5, ss.928, 2002 (SCI-Expanded, Scopus)

149. Do mobile telephones have adverse effects on the functions of implantable cardioverter-defibrillators?

Tandoǧan I., Ileri M., Yetkin E., TEMİZHAN A., Aras D., Sezgin A. T., et al.

Anadolu Kardiyoloji Dergisi , cilt.2, sa.1, ss.45-48, 2002 (Scopus)

150. Comparison of thallium-201 exercise SPECT and dobutamine stress echocardiography for diagnosis of coronary artery disease in patients with left bundle branch block

Tandoan I., Yetkin E., Yanik A., Ulusoy F. V., TEMİZHAN A., Cehreli S., et al.

International Journal of Cardiovascular Imaging , cilt.17, sa.5, ss.339-345, 2001 (SCI-Expanded, Scopus)

151. Is there any effect of chronobiological changes on coronary angioplasty

TEMİZHAN A., DİNÇER İ., Pamir G., ALPMAN A., Oral D.

European Journal of Cardiovascular Prevention & Rehabilitation , cilt.8, sa.1, ss.15-19, 2001 (Scopus)

152. The effects of Ramadan fasting on blood lipid levels [2]

TEMİZHAN A., Tandogan I., Dönderici Ö., Demirbas B.

American Journal of Medicine , cilt.109, sa.4, ss.341-342, 2000 (SCI-Expanded, Scopus)

153. Is there any effect of Ramadan fasting on acute coronary heart disease events?

TEMİZHAN A., Dönderici Ö., Ouz D., Demirbas B.

International Journal of Cardiology , cilt.70, sa.2, ss.149-153, 1999 (SCI-Expanded, Scopus)

154. Effect of ramadan on peptic ulcer complications

Dönderici O., TEMİZHAN A., Küçükbaş T., Eskiog̀lu E.

Scandinavian Journal of Gastroenterology , cilt.29, sa.7, ss.603-606, 1994 (Scopus)

Yayınlar & Eserler